[HTML] mdpi.com

[HTML][HTML] Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignancies

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - mdpi.com
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …
被引用次数：66 相关文章
[PDF] core.ac.uk

[PDF][PDF] Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

DG Efremov, S Turkalj, L Laurenti - core.ac.uk
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Mechanisms of b cell receptor activation and responses to b cell receptor inhibitors in b cell malignancies

DG Efremov, S Turkalj, L Laurenti - CANCERS, 2020 - publicatt.unicatt.it
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - search.ebscohost.com
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - pubmed.ncbi.nlm.nih.gov
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - europepmc.org
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …
[HTML] nih.gov

[HTML][HTML] Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - ncbi.nlm.nih.gov
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …
[PDF] semanticscholar.org

[PDF][PDF] Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

DG Efremov, S Turkalj, L Laurenti - pdfs.semanticscholar.org
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …
[PDF] unicatt.it

[PDF][PDF] Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

DG Efremov, S Turkalj, L Laurenti - publicatt.unicatt.it
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - europepmc.org
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …